title: Iloprost, a stable analogue of PGI2: clinical results and pathophysiological considerations.
authors.affiliation: Research Laboratories of Schering AG, Berlin, West Germany.
authors.forename: G
authors.initials: G
authors.lastname: Stock
authors.forename: B
authors.initials: B
authors.lastname: Müller
authors.forename: T
authors.initials: T
authors.lastname: Krais
authors.forename: E
authors.initials: E
authors.lastname: Schillinger
mesh_terms: D001157:Arterial Occlusive Diseases / Q000188:drug therapy* / Q000503:physiopathology; D001792:Blood Platelets / Q000187:drug effects; D002448:Cell Adhesion / Q000187:drug effects; D002986:Clinical Trials as Topic; D004730:Endothelium, Vascular / Q000187:drug effects; D006801:Humans; D016285:Iloprost / Q000627:therapeutic use*; D007962:Leukocytes / Q000187:drug effects; D008833:Microcirculation / Q000187:drug effects; D013927:Thrombosis / Q000188:drug therapy
chemical_list: D016285:Iloprost